FSLSX
Price
$55.18
Change
+$0.29 (+0.53%)
Updated
Jul 3 closing price
Net Assets
1.7B
MVCAX
Price
$31.58
Change
+$0.12 (+0.38%)
Updated
Jul 3 closing price
Net Assets
17.33B
Interact to see
Advertisement

FSLSX vs MVCAX

Header iconFSLSX vs MVCAX Comparison
Open Charts FSLSX vs MVCAXBanner chart's image
Fidelity Value Strategies
Price$55.18
Change+$0.29 (+0.53%)
VolumeN/A
Net Assets1.7B
MFS Mid Cap Value A
Price$31.58
Change+$0.12 (+0.38%)
VolumeN/A
Net Assets17.33B
FSLSX vs MVCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSLSX vs. MVCAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLSX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.3B vs. FSLSX (1.7B). MVCAX pays higher dividends than FSLSX: MVCAX (0.87) vs FSLSX (0.77). FSLSX was incepted earlier than MVCAX: FSLSX (42 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than FSLSX (0.80). FSLSX is a more actively managed with annual turnover of: 61.00 vs. MVCAX (27.00). FSLSX has a lower initial minimum investment than MVCAX: FSLSX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : 1.09 vs. FSLSX (-2.02). FSLSX return over 5 years is better than : 85.30 vs. MVCAX (60.39).
FSLSXMVCAXFSLSX / MVCAX
Total Expense Ratio0.800.9981%
Annual Report Gross Expense Ratio0.801.0080%
Fund Existence42 years24 years-
Gain YTD0.8592.93429%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B17.3B10%
Annual Yield % from dividends0.770.8788%
Returns for 1 year-2.021.09-185%
Returns for 3 years22.7718.70122%
Returns for 5 years85.3060.39141%
Returns for 10 years27.1264.6142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHFF1.300.01
+0.78%
Arch Biopartners Inc.
SBKO14.15N/A
N/A
Summit Bank Group, Inc.
CEVMF125.65N/A
N/A
CTS Eventim AG & Co. KGAA
NICFF22.86N/A
N/A
Nichias Corp.
ADYEY18.00-0.01
-0.06%
Adyen N.V.